Kenichiro Yoshida

Onset of neutropenia as an indicator of treatment response in the phase 3 RECOURSE trial of trifluridine/tipiracil (TAS-102) versus placebo in patients with metastatic colorectal cancer.

H. Lenz, B. Tran, R. Mayer, 2017 .